Resmed Inc. [RMD] stock prices are up 0.38% to $237.93 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The RMD shares have lost -0.21% over the last week, with a monthly amount drifted -5.93%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Resmed Inc. [NYSE: RMD] stock has seen the most recent analyst activity on September 24, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $280. Previously, Wolfe Research downgraded its rating to Underperform on September 18, 2024, and kept the price target unchanged to $180. On September 04, 2024, downgrade downgraded it’s rating to Hold. Oppenheimer downgraded its rating to a Perform. Citigroup downgraded its rating to a Neutral. In a note dated October 27, 2023, Morgan Stanley upgraded an Overweight rating on this stock and revised its target price from $180 to $169.
The stock price of Resmed Inc. [RMD] has been fluctuating between $132.24 and $255.18 over the past year. Currently, Wall Street analysts expect the stock to reach $219.13 within the next 12 months. Resmed Inc. [NYSE: RMD] shares were valued at $237.93 at the most recent close of the market. An investor can expect a potential drop of -7.9% based on the average RMD price forecast.
Analyzing the RMD fundamentals
The Resmed Inc. [NYSE:RMD] reported sales of 4.69B for trailing twelve months, representing a surge of 9.01%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.22 and Total Capital is 0.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 235.00 points at the first support level, and at 232.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 239.66, and for the 2nd resistance point, it is at 241.38.
Ratios To Look Out For
It’s worth pointing out that Resmed Inc. [NYSE:RMD]’s Current Ratio is 2.59. On the other hand, the Quick Ratio is 1.69, and the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 7.45, the price to book ratio is 7.19 and price to earnings (TTM) ratio is 34.37.
Transactions by insiders
Recent insider trading involved Sandercock Brett, Chief Financial Officer, that happened on Oct 08 ’24 when 1000.0 shares were sold. Chief Executive Officer, Farrell Michael J. completed a deal on Oct 07 ’24 to sell 14683.0 shares. Meanwhile, Officer Sandercock Brett bought 1000.0 shares on Oct 08 ’24.
